Is Buprenorphine legal in Timor-Leste?

Also known as: subutex

Legal status

Buprenorphine is named at Table II-C, item 2, of Lei 2/2017's Anexo II: "Buprenorfina - 21-ciclopropil-7 alfa [(s) 1-hidroxi-1,2,2-trimetilpropil]-6,14-endoetano-6,7,8,14-tetra-hidrooripavina" (English: buprenorphine, the standard IUPAC-style oripavine derivative name). Article 4, paragraph 2, states that Table II corresponds to Schedules I, II and III of the 1971 Convention, and article 5, paragraph 2(f), places short-acting barbiturate-type and non-barbiturate hypnotic substances in the II-C sub-table where buprenorphine sits alongside amobarbital, ketamine and methaqualone.

Consequences if caught

Article 7, paragraphs 1 and 2, apply the tabelas I a III band to a Table II substance: 5 to 15 years' imprisonment for unauthorized cultivation, production, manufacture, extraction, preparation, offering, sale, distribution, purchase, transport, import, export or possession, and 6 to 16 years where the person holds an authorization but acts against it. Article 9 aggravates both figures by two thirds at the minimum and maximum for listed factors (distribution to many people, supply to minors or the mentally ill, acting within a criminal organization, among others). Article 10 punishes founding, financing or joining a criminal association formed to commit article 7 or 8 crimes: 10 to 25 years for a founder, 5 to 15 years for a member, 12 to 25 years for a leader. Buprenorphine does not appear in Annex I's 16 item daily reference quantity table, so article 11's reduced-gravity band, 1 to 5 years where illicitude is considerably diminished for a Table I to III substance, has no pinned quantity figure for buprenorphine specifically; the reduced band itself still applies on the other listed factors in article 11, paragraph 1. Article 12 gives an intermediate band where the sole purpose of the article 7 act was to obtain the substance for personal use: up to 2 years' imprisonment or a fine. Article 26 punishes illicit personal consumption, or cultivation, production, manufacture, extraction, preparation, acquisition or possession for exclusive personal use, with up to 1 year's imprisonment or a fine of up to 120 days. Article 26, paragraph 2, raises this to up to 2 years' imprisonment or a fine of up to 240 days where the quantity found exceeds five times the Annex I reference figure; none of the 16 substances in Annex I's table include this one, so no figure is pinned here specifically. Article 26, paragraph 3, allows an occasional user to be excused penalty entirely in the paragraph 1 case. No death penalty is provided anywhere in Lei 2/2017. The Constitution of the Democratic Republic of Timor-Leste, quoted in Lei 2/2017's own preamble, states that the State "proíbe, em absoluto, a existência da pena de morte" (English: absolutely prohibits the existence of the death penalty); the preamble cites this as part of why Lei 2/2017 replaced Indonesia's Law 5/1997, whose own penalty scheme for drug trafficking included the death penalty.

If prescribed or medical

Article 6, paragraph 1, subjects buprenorphine, as a Table I to IV substance, to licensing, conditions and authorizations issued by the Ministério da Saúde, on terms the article defers to a separate instrument ("nos termos a definir em diploma próprio") that has not been located. Decreto-Lei 2/2025 regulates pharmacy licensing generally and cross-refers to Lei 2/2017's tables for its definition of a controlled substance, without itself naming which Table I to IV substances a doctor may prescribe, so it is not cited here as a prescription route. No prescription or medical-supply pathway for buprenorphine, including an opioid-substitution-therapy route, under Lei 2/2017 has therefore been established by this reading.

Documentation

Decreto-Lei 19/2009, de 8 de Abril, is Timor-Leste's Penal Code, and Lei 2/2017's own preamble states that the Penal Code's third amendment, Lei 5/2013, de 14 de Agosto, "não se traduziu na criminalização do tráfico ilícito e o consumo de estupefacientes e substâncias psicotrópicas" (English: did not result in the criminalization of illicit trafficking and consumption of narcotic drugs and psychotropic substances), and that before Lei 2/2017 the operative drug law was Indonesia's Law 5/1997, carried over under article 165 of the Constitution of the Democratic Republic of Timor-Leste. Lei 2/2017 is accordingly Timor-Leste's first domestic drug-trafficking law; no later one has been found, and no drug-trafficking chapter of the Penal Code has been located. No separate traveller or import-permit rule for buprenorphine, beyond the Ministério da Saúde licensing regime in article 6, which is itself deferred to an instrument not yet located, has been found.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Timor-Leste’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.